Biomarkers Market 2027 By Type, Products, Disease Detection, Application | The Insight Partners

Biomarkers Market to 2027 - Global Analysis and Forecasts By Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers); Products (Software, Services, Consumables); Disease Detection (Cancer, Neurological Disease, Immunological Disease, Cardiovascular, others); Application (Drug Discovery, Personalized Medicine, Diagnostic Development, Disease Risk Assessment, Others)

Report Code: TIPHE100000974 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

Biomarker is an indicator used to evaluate the health status of an individual. In medical terms, a measurable biomarker is a chemical component which reflects the presence as well as the severity of the disease. Biomarkers have an important function in the early detection of various diseases. These compounds are introduced into the body in order to estimate the health condition of an individual. The biomarker reacts with the target molecule or cell within the body. The byproducts of the chemical reaction between the biomarker and the target molecule is analyzed with the help of various tests to evaluate the severity of a disease in an individual.

MARKET DYNAMICS

Growing incidence of cancer & neurological diseases, growing initiatives for biomarker research and increasing availability of funds for biomarker research are anticipated to be the driving factors for the growth of biomarkers market. Rise in the use of biomarkers for disease detection in economies is expected to provide growth opportunities to the players operating in the market in the future years.

MARKET SCOPE

The "Global Biomarkers Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global medical device market trend analysis. The report aims to provide an overview of biomarkers market with detailed market segmentation by type, product, disease detection, application and geography. The global biomarkers market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Biomarkers market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global biomarkers market is segmented on the basis of type, product, disease detection and application. Based on type, the market is segmented as efficacy biomarkers, safety biomarkers and validation biomarkers. On the basis of product, the global biomarkers market is segmented into software, services and consumables. Based on disease detection, the market is segmented as cancer, neurological disease, immunological disease, cardiovascular and others. Based on application, the market is segmented as drug discovery, personalized medicine, diagnostic development, disease risk assessment and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global biomarkers market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The biomarkers market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting biomarkers market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the biomarkers market in these regions.

MARKET PLAYERS

The reports cover key developments in the biomarkers market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from biomarkers market are anticipated to lucrative growth opportunities in the future with the rising demand for biomarkers in the global market. Below mentioned is the list of few companies engaged in the biomarkers market

The report also includes the profiles of key biomarkers market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  •  Thermo Fisher Scientific Inc.
  •  QIAGEN
  •  Hologic, Inc.
  •  F. Hoffmann-La Roche Ltd
  •  Janssen Global Services, LLC
  •  Siemens Healthcare GmbH
  •  Cisbio
  •  Biomarker Technologies, Inc.
  •  BD
  •  Bio-Rad Laboratories, Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

 

TABLE OF CONTENTS

1. INTRODUCTION
 1.1. SCOPE OF THE STUDY
 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
 1.3. MARKET SEGMENTATION
 1.3.1 Biomarkers Market - By Type
 1.3.2 Biomarkers Market - By Products
 1.3.3 Biomarkers Market - By Disease Detection
 1.3.4 Biomarkers Market - By Application
 1.3.5 Biomarkers Market - By Region
 1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIOMARKERS MARKET LANDSCAPE
 4.1. OVERVIEW
 4.2. PEST ANALYSIS
 4.2.1 North America - Pest Analysis
 4.2.2 Europe - Pest Analysis
 4.2.3 Asia-Pacific - Pest Analysis
 4.2.4 Middle East and Africa - Pest Analysis
 4.2.5 South and Central America - Pest Analysis
 4.3. EXPERT OPINIONS
5. BIOMARKERS MARKET - KEY MARKET DYNAMICS
 5.1. KEY MARKET DRIVERS
 5.2. KEY MARKET RESTRAINTS
 5.3. KEY MARKET OPPORTUNITIES
 5.4. FUTURE TRENDS
 5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIOMARKERS MARKET - GLOBAL MARKET ANALYSIS
 6.1. BIOMARKERS - GLOBAL MARKET OVERVIEW
 6.2. BIOMARKERS - GLOBAL MARKET AND FORECAST TO 2027
 6.3. MARKET POSITIONING/MARKET SHARE
7. BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
 7.1. OVERVIEW
 7.2. TYPE MARKET FORECASTS AND ANALYSIS
 7.3. EFFICACY BIOMARKERS
 7.3.1. Overview
 7.3.2. Efficacy Biomarkers Market Forecast and Analysis
 7.3.3. Pharmacodynamic Market
 7.3.3.1. Overview
 7.3.3.2. Pharmacodynamic Market Forecast and Analysis
 7.3.4. Prognostive Market
 7.3.4.1. Overview
 7.3.4.2. Prognostive Market Forecast and Analysis
 7.3.5. Predictive Biomarkers Market
 7.3.5.1. Overview
 7.3.5.2. Predictive Biomarkers Market Forecast and Analysis
 7.4. SAFETY BIOMARKERS
 7.4.1. Overview
 7.4.2. Safety Biomarkers Market Forecast and Analysis
 7.5. VALIDATION BIOMARKERS
 7.5.1. Overview
 7.5.2. Validation Biomarkers Market Forecast and Analysis
8. BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCTS
 8.1. OVERVIEW
 8.2. PRODUCTS MARKET FORECASTS AND ANALYSIS
 8.3. SOFTWARE
 8.3.1. Overview
 8.3.2. Software Market Forecast and Analysis
 8.4. SERVICES
 8.4.1. Overview
 8.4.2. Services Market Forecast and Analysis
 8.5. CONSUMABLES
 8.5.1. Overview
 8.5.2. Consumables Market Forecast and Analysis
9. BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE DETECTION
 9.1. OVERVIEW
 9.2. DISEASE DETECTION MARKET FORECASTS AND ANALYSIS
 9.3. CANCER
 9.3.1. Overview
 9.3.2. Cancer Market Forecast and Analysis
 9.4. NEUROLOGICAL DISEASE
 9.4.1. Overview
 9.4.2. Neurological Disease Market Forecast and Analysis
 9.5. IMMUNOLOGICAL DISEASE
 9.5.1. Overview
 9.5.2. Immunological Disease Market Forecast and Analysis
 9.6. CARDIOVASCULAR
 9.6.1. Overview
 9.6.2. Cardiovascular Market Forecast and Analysis
 9.7. OTHER
 9.7.1. Overview
 9.7.2. Other Market Forecast and Analysis
10. BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
 10.1. OVERVIEW
 10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
 10.3. DRUG DISCOVERY
 10.3.1. Overview
 10.3.2. Drug Discovery Market Forecast and Analysis
 10.4. PERSONALIZED MEDICINE
 10.4.1. Overview
 10.4.2. Personalized Medicine Market Forecast and Analysis
 10.5. DIAGNOSTIC DEVELOPMENT
 10.5.1. Overview
 10.5.2. Diagnostic Development, Market Forecast and Analysis
 10.6. DISEASE RISK ASSESSMENT
 10.6.1. Overview
 10.6.2. Disease Risk Assessment, Market Forecast and Analysis
 10.7. OTHER
 10.7.1. Overview
 10.7.2. Other Market Forecast and Analysis
11. BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
 11.1. NORTH AMERICA
 11.1.1 North America Biomarkers Market Overview
 11.1.2 North America Biomarkers Market Forecasts and Analysis
 11.1.3 North America Biomarkers Market Forecasts and Analysis - By Type
 11.1.4 North America Biomarkers Market Forecasts and Analysis - By Products
 11.1.5 North America Biomarkers Market Forecasts and Analysis - By Disease Detection
 11.1.6 North America Biomarkers Market Forecasts and Analysis - By Application
 11.1.7 North America Biomarkers Market Forecasts and Analysis - By Countries
 11.1.7.1 United States Biomarkers Market
 11.1.7.1.1 United States Biomarkers Market by Type
 11.1.7.1.2 United States Biomarkers Market by Products
 11.1.7.1.3 United States Biomarkers Market by Disease Detection
 11.1.7.1.4 United States Biomarkers Market by Application
 11.1.7.2 Canada Biomarkers Market
 11.1.7.2.1 Canada Biomarkers Market by Type
 11.1.7.2.2 Canada Biomarkers Market by Products
 11.1.7.2.3 Canada Biomarkers Market by Disease Detection
 11.1.7.2.4 Canada Biomarkers Market by Application
 11.1.7.3 Mexico Biomarkers Market
 11.1.7.3.1 Mexico Biomarkers Market by Type
 11.1.7.3.2 Mexico Biomarkers Market by Products
 11.1.7.3.3 Mexico Biomarkers Market by Disease Detection
 11.1.7.3.4 Mexico Biomarkers Market by Application
 11.2. EUROPE
 11.2.1 Europe Biomarkers Market Overview
 11.2.2 Europe Biomarkers Market Forecasts and Analysis
 11.2.3 Europe Biomarkers Market Forecasts and Analysis - By Type
 11.2.4 Europe Biomarkers Market Forecasts and Analysis - By Products
 11.2.5 Europe Biomarkers Market Forecasts and Analysis - By Disease Detection
 11.2.6 Europe Biomarkers Market Forecasts and Analysis - By Application
 11.2.7 Europe Biomarkers Market Forecasts and Analysis - By Countries
 11.2.7.1 Germany Biomarkers Market
 11.2.7.1.1 Germany Biomarkers Market by Type
 11.2.7.1.2 Germany Biomarkers Market by Products
 11.2.7.1.3 Germany Biomarkers Market by Disease Detection
 11.2.7.1.4 Germany Biomarkers Market by Application
 11.2.7.2 France Biomarkers Market
 11.2.7.2.1 France Biomarkers Market by Type
 11.2.7.2.2 France Biomarkers Market by Products
 11.2.7.2.3 France Biomarkers Market by Disease Detection
 11.2.7.2.4 France Biomarkers Market by Application
 11.2.7.3 Italy Biomarkers Market
 11.2.7.3.1 Italy Biomarkers Market by Type
 11.2.7.3.2 Italy Biomarkers Market by Products
 11.2.7.3.3 Italy Biomarkers Market by Disease Detection
 11.2.7.3.4 Italy Biomarkers Market by Application
 11.2.7.4 Spain Biomarkers Market
 11.2.7.4.1 Spain Biomarkers Market by Type
 11.2.7.4.2 Spain Biomarkers Market by Products
 11.2.7.4.3 Spain Biomarkers Market by Disease Detection
 11.2.7.4.4 Spain Biomarkers Market by Application
 11.2.7.5 United Kingdom Biomarkers Market
 11.2.7.5.1 United Kingdom Biomarkers Market by Type
 11.2.7.5.2 United Kingdom Biomarkers Market by Products
 11.2.7.5.3 United Kingdom Biomarkers Market by Disease Detection
 11.2.7.5.4 United Kingdom Biomarkers Market by Application
 11.3. ASIA-PACIFIC
 11.3.1 Asia-Pacific Biomarkers Market Overview
 11.3.2 Asia-Pacific Biomarkers Market Forecasts and Analysis
 11.3.3 Asia-Pacific Biomarkers Market Forecasts and Analysis - By Type
 11.3.4 Asia-Pacific Biomarkers Market Forecasts and Analysis - By Products
 11.3.5 Asia-Pacific Biomarkers Market Forecasts and Analysis - By Disease Detection
 11.3.6 Asia-Pacific Biomarkers Market Forecasts and Analysis - By Application
 11.3.7 Asia-Pacific Biomarkers Market Forecasts and Analysis - By Countries
 11.3.7.1 Australia Biomarkers Market
 11.3.7.1.1 Australia Biomarkers Market by Type
 11.3.7.1.2 Australia Biomarkers Market by Products
 11.3.7.1.3 Australia Biomarkers Market by Disease Detection
 11.3.7.1.4 Australia Biomarkers Market by Application
 11.3.7.2 China Biomarkers Market
 11.3.7.2.1 China Biomarkers Market by Type
 11.3.7.2.2 China Biomarkers Market by Products
 11.3.7.2.3 China Biomarkers Market by Disease Detection
 11.3.7.2.4 China Biomarkers Market by Application
 11.3.7.3 India Biomarkers Market
 11.3.7.3.1 India Biomarkers Market by Type
 11.3.7.3.2 India Biomarkers Market by Products
 11.3.7.3.3 India Biomarkers Market by Disease Detection
 11.3.7.3.4 India Biomarkers Market by Application
 11.3.7.4 Japan Biomarkers Market
 11.3.7.4.1 Japan Biomarkers Market by Type
 11.3.7.4.2 Japan Biomarkers Market by Products
 11.3.7.4.3 Japan Biomarkers Market by Disease Detection
 11.3.7.4.4 Japan Biomarkers Market by Application
 11.3.7.5 South Korea Biomarkers Market
 11.3.7.5.1 South Korea Biomarkers Market by Type
 11.3.7.5.2 South Korea Biomarkers Market by Products
 11.3.7.5.3 South Korea Biomarkers Market by Disease Detection
 11.3.7.5.4 South Korea Biomarkers Market by Application
 11.4. MIDDLE EAST AND AFRICA
 11.4.1 Middle East and Africa Biomarkers Market Overview
 11.4.2 Middle East and Africa Biomarkers Market Forecasts and Analysis
 11.4.3 Middle East and Africa Biomarkers Market Forecasts and Analysis - By Type
 11.4.4 Middle East and Africa Biomarkers Market Forecasts and Analysis - By Products
 11.4.5 Middle East and Africa Biomarkers Market Forecasts and Analysis - By Disease Detection
 11.4.6 Middle East and Africa Biomarkers Market Forecasts and Analysis - By Application
 11.4.7 Middle East and Africa Biomarkers Market Forecasts and Analysis - By Countries
 11.4.7.1 South Africa Biomarkers Market
 11.4.7.1.1 South Africa Biomarkers Market by Type
 11.4.7.1.2 South Africa Biomarkers Market by Products
 11.4.7.1.3 South Africa Biomarkers Market by Disease Detection
 11.4.7.1.4 South Africa Biomarkers Market by Application
 11.4.7.2 Saudi Arabia Biomarkers Market
 11.4.7.2.1 Saudi Arabia Biomarkers Market by Type
 11.4.7.2.2 Saudi Arabia Biomarkers Market by Products
 11.4.7.2.3 Saudi Arabia Biomarkers Market by Disease Detection
 11.4.7.2.4 Saudi Arabia Biomarkers Market by Application
 11.4.7.3 U.A.E Biomarkers Market
 11.4.7.3.1 U.A.E Biomarkers Market by Type
 11.4.7.3.2 U.A.E Biomarkers Market by Products
 11.4.7.3.3 U.A.E Biomarkers Market by Disease Detection
 11.4.7.3.4 U.A.E Biomarkers Market by Application
 11.5. SOUTH AND CENTRAL AMERICA
 11.5.1 South and Central America Biomarkers Market Overview
 11.5.2 South and Central America Biomarkers Market Forecasts and Analysis
 11.5.3 South and Central America Biomarkers Market Forecasts and Analysis - By Type
 11.5.4 South and Central America Biomarkers Market Forecasts and Analysis - By Products
 11.5.5 South and Central America Biomarkers Market Forecasts and Analysis - By Disease Detection
 11.5.6 South and Central America Biomarkers Market Forecasts and Analysis - By Application
 11.5.7 South and Central America Biomarkers Market Forecasts and Analysis - By Countries
 11.5.7.1 Brazil Biomarkers Market
 11.5.7.1.1 Brazil Biomarkers Market by Type
 11.5.7.1.2 Brazil Biomarkers Market by Products
 11.5.7.1.3 Brazil Biomarkers Market by Disease Detection
 11.5.7.1.4 Brazil Biomarkers Market by Application
 11.5.7.2 Argentina Biomarkers Market
 11.5.7.2.1 Argentina Biomarkers Market by Type
 11.5.7.2.2 Argentina Biomarkers Market by Products
 11.5.7.2.3 Argentina Biomarkers Market by Disease Detection
 11.5.7.2.4 Argentina Biomarkers Market by Application
12. INDUSTRY LANDSCAPE
 12.1. MERGERS AND ACQUISITIONS
 12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
 12.3. NEW PRODUCT LAUNCHES
 12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. BIOMARKERS MARKET, KEY COMPANY PROFILES
 13.1. THERMO FISHER SCIENTIFIC INC.
 13.1.1. Key Facts
 13.1.2. Business Description
 13.1.3. Products and Services
 13.1.4. Financial Overview
 13.1.5. SWOT Analysis
 13.1.6. Key Developments
 13.2. QIAGEN
 13.2.1. Key Facts
 13.2.2. Business Description
 13.2.3. Products and Services
 13.2.4. Financial Overview
 13.2.5. SWOT Analysis
 13.2.6. Key Developments
 13.3. HOLOGIC, INC.
 13.3.1. Key Facts
 13.3.2. Business Description
 13.3.3. Products and Services
 13.3.4. Financial Overview
 13.3.5. SWOT Analysis
 13.3.6. Key Developments
 13.4. F. HOFFMANN-LA ROCHE LTD
 13.4.1. Key Facts
 13.4.2. Business Description
 13.4.3. Products and Services
 13.4.4. Financial Overview
 13.4.5. SWOT Analysis
 13.4.6. Key Developments
 13.5. JANSSEN GLOBAL SERVICES, LLC
 13.5.1. Key Facts
 13.5.2. Business Description
 13.5.3. Products and Services
 13.5.4. Financial Overview
 13.5.5. SWOT Analysis
 13.5.6. Key Developments
 13.6. SIEMENS HEALTHCARE GMBH
 13.6.1. Key Facts
 13.6.2. Business Description
 13.6.3. Products and Services
 13.6.4. Financial Overview
 13.6.5. SWOT Analysis
 13.6.6. Key Developments
 13.7. CISBIO
 13.7.1. Key Facts
 13.7.2. Business Description
 13.7.3. Products and Services
 13.7.4. Financial Overview
 13.7.5. SWOT Analysis
 13.7.6. Key Developments
 13.8. BIOMARKER TECHNOLOGIES, INC.
 13.8.1. Key Facts
 13.8.2. Business Description
 13.8.3. Products and Services
 13.8.4. Financial Overview
 13.8.5. SWOT Analysis
 13.8.6. Key Developments
 13.9. BD
 13.9.1. Key Facts
 13.9.2. Business Description
 13.9.3. Products and Services
 13.9.4. Financial Overview
 13.9.5. SWOT Analysis
 13.9.6. Key Developments
 13.10. BIO-RAD LABORATORIES, INC.
 13.10.1. Key Facts
 13.10.2. Business Description
 13.10.3. Products and Services
 13.10.4. Financial Overview
 13.10.5. SWOT Analysis
 13.10.6. Key Developments
14. APPENDIX
 14.1. ABOUT THE INSIGHT PARTNERS
 14.2. GLOSSARY OF TERMS

 

The List of Companies

1. Thermo Fisher Scientific Inc.
2. QIAGEN
3. Hologic, Inc.
4. F. Hoffmann-La Roche Ltd
5. Janssen Global Services, LLC
6. Siemens Healthcare GmbH
7. Cisbio
8. Biomarker Technologies, Inc.
9. BD
10. Bio-Rad Laboratories, Inc.